Palantir Technologies Inc. (PLTR) Spending and interest coverage
- R&D / revenue · 12 months: Value 10.42%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 13.57%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 10.42% | Research and development expense / revenue. Period ending 2026-06-30. $641.24M ÷ $6.16B × 100 ≈ 10.42% |
| Stock-based compensation / revenue · 12 months | 13.57% | Share-based compensation / revenue. Period ending 2026-06-30. $835.52M ÷ $6.16B × 100 ≈ 13.57% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 641.24M USD | Research and Development Expense |
| Revenue | 6.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 835.52M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.63B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $641.24M | $6.16B | $835.52M | $2.63B | (m) | 10.42% | 13.57% | (m) | (m) |
| 2026-03-31 | $583.77M | $5.22B | $730.29M | $1.99B | (m) | 11.17% | 13.98% | (m) | (m) |
| 2025-12-31 | $557.68M | $4.48B | $684.03M | $1.41B | (m) | 12.46% | 15.28% | (m) | (m) |
| 2025-09-30 | $585.63M | $3.90B | $769.43M | $849.66M | (m) | 15.03% | 19.75% | (m) | (m) |
| 2025-06-30 | $558.99M | $3.44B | $739.53M | $569.55M | (m) | 16.25% | 21.49% | (m) | (m) |
| 2025-03-31 | $532.73M | $3.12B | $721.33M | $405.57M | (m) | 17.10% | 23.16% | (m) | (m) |
| 2024-12-31 | $507.88M | $2.87B | $691.64M | $310.40M | (m) | 17.72% | 24.14% | (m) | (m) |
| 2024-09-30 | $445.66M | $2.65B | $542.45M | $365.15M | (m) | 16.84% | 20.50% | (m) | (m) |
| 2024-06-30 | $433.81M | $2.48B | $514.40M | $292.00M | (m) | 17.50% | 20.75% | (m) | (m) |
| 2024-03-31 | $424.56M | $2.33B | $486.84M | $196.73M | (m) | 18.19% | 20.86% | (m) | (m) |
| 2023-12-31 | $404.62M | $2.23B | $475.90M | $119.97M | $3.47M | 18.19% | 21.39% | 34.57× | Reported |
| 2023-09-30 | $377.38M | $2.13B | $472.69M | $36.35M | $5.05M | 17.76% | 22.24% | 7.20× | Reported |
| 2023-06-30 | $372.54M | $2.05B | $498.62M | $-65.83M | $5.39M | 18.22% | 24.38% | -12.22× | Reported |
| 2023-03-31 | $361.18M | $1.98B | $530.19M | $-117.65M | $4.74M | 18.20% | 26.71% | -24.83× | Reported |
| 2022-12-31 | $359.68M | $1.91B | $564.80M | $-161.20M | $4.06M | 18.87% | 29.63% | -39.72× | Reported |
| 2022-09-30 | $361.81M | $1.83B | $602.31M | $-202.32M | $2.95M | 19.77% | 32.91% | -68.65× | Reported |
| 2022-06-30 | $355.26M | $1.74B | $646.83M | $-232.07M | $2.47M | 20.37% | 37.08% | -93.80× | Reported |
| 2022-03-31 | $377.62M | $1.65B | $733.81M | $-336.47M | $2.39M | 22.93% | 44.55% | -140.55× | Reported |
| 2021-12-31 | $387.49M | $1.54B | $778.22M | $-411.05M | $3.64M | 25.13% | 50.47% | -112.92× | Reported |
| 2021-09-30 | $397.44M | $1.43B | $853.10M | $-508.68M | $4.85M | 27.77% | 59.61% | -104.82× | Reported |
| 2021-06-30 | $617.04M | $1.33B | $1.52B | $-1.26B | $6.33M | 46.45% | 114.07% | -199.80× | Reported |
| 2021-03-31 | $593.33M | $1.20B | $1.41B | $-1.22B | $11.38M | 49.26% | 117.08% | -106.94× | Reported |
| 2020-12-31 | $560.66M | $1.09B | $1.27B | $-1.17B | $14.14M | 51.31% | 116.29% | -83.01× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $305.56M | $742.55M | $241.97M | $-576.44M | $3.06M | 41.15% | 32.59% | -188.32× | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $285.45M | $595.41M | $248.50M | $-623.44M | $3.44M | 47.94% | 41.74% | -181.23× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.